Comparison of hypoxia-induced pulmonary hypertension rat models caused by different hypoxia protocols. 2023

Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Key Laboratory of Heart and Lung, Zhejiang, China.

Background and aim: Pulmonary hypertension (PH) is a serious and even fatal disorder with limited treatment strategies. The hypoxia-induced pulmonary hypertension (HPH) rat model is commonly used in this field. While the HPH rat model has strong predictability and repeatability, the model is a chronic model, making it time-consuming, costly, and complicated and limiting the progress of the experiments. Currently, there is no uniform international standard for the HPH model. Our study aimed to find a relatively effective and efficient HPH modeling protocol. Methods: We established HPH rat models with different total hypoxia periods and different daily hypoxia times, and assessed different hypoxia modeling modes in multiple dimensions, such as haemodynamics, right ventricular (RV) hypertrophy, pulmonary arterial remodeling, muscularization, inflammation, and collagen deposition. Results: Longer daily hypoxia time resulted in higher mean pulmonary arterial pressure (mPAP)/right ventricular systolic pressure (RVSP) and more obvious RV hypertrophy, as well as more severe pulmonary arterial remodeling and muscularization, regardless of the total period of hypoxia (3- or 4-week). Moreover, pulmonary perivascular macrophages and collagen deposition showed daily hypoxia time-dependent increases, both in 3- and 4-week hypoxia groups. Conclusion: Our findings showed that the 3-week continuous hypoxia mode was a relatively efficient way to reduce the time needed to induce significant disease phenotypes, which offered methodological evidence for future studies in building HPH models.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D017380 Hypertrophy, Right Ventricular Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality. Right Ventricular Hypertrophy,Ventricular Hypertrophy, Right,Hypertrophies, Right Ventricular,Right Ventricular Hypertrophies,Ventricular Hypertrophies, Right
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D066253 Vascular Remodeling The active alterations of vascular wall structures, often leading to elevated VASCULAR RESISTANCE. It is associated with AGING; ATHEROSCLEROSIS; DIABETES MELLITUS; HYPERTENSION; PREGNANCY; PULMONARY HYPERTENSION; and STROKE, but is also a normal part of EMBRYOGENESIS. Pulmonary Arterial Remodeling,Arterial Remodeling, Pulmonary,Arterial Remodelings, Pulmonary,Pulmonary Arterial Remodelings,Remodeling, Pulmonary Arterial,Remodeling, Vascular,Remodelings, Pulmonary Arterial,Remodelings, Vascular,Vascular Remodelings

Related Publications

Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
October 2015, European review for medical and pharmacological sciences,
Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
December 2003, Veterinary research communications,
Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
March 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
October 1978, The American review of respiratory disease,
Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
August 2016, Toxicology and applied pharmacology,
Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
January 2019, American journal of respiratory cell and molecular biology,
Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
October 2007, Respiratory medicine,
Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
January 2016, Molecular and cellular biochemistry,
Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
July 2001, Circulation,
Gexiang Cai, and Yaxin Zhang, and Xinghong Wang, and Shini Li, and Yushan Cheng, and Xiaoying Huang
March 2001, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
Copied contents to your clipboard!